Exploring Factors behind Patient Nonadherence to Intravitreal Anti-Vascular Endothelial Growth Factor Injections in Macular Diseases

• Published in: Ophthalmic research Vol. 68; no. 1; pp. 221 - 227
• Main Authors: Naaman, Efrat, Yanir-Prat, Noa, Shair-Nakhleh, Diana, Bar, Nitai, Miller, Beata, Fishman, Anna, Zayit-Soudry, Shiri
• Format: Journal Article
• Language: English
• Published: Switzerland Karger Publishers 27.01.2025
• Subjects: Aged; Angiogenesis Inhibitors - administration & dosage; Bevacizumab - administration & dosage; Cross-Sectional Studies; Female; Humans; Intravitreal Injections; Male; Middle Aged; Ranibizumab - administration & dosage; Retrospective Studies; Vascular Endothelial Growth Factor A - antagonists & inhibitors; Visual Acuity; Treatment adherence; Macular diseases; Intravitreal injections; No-show

Introduction: In recent years, intravitreal injections (IVTs) of vascular endothelial growth factor (VEGF) inhibitors have become the standard of care for several macular disorders. Frequently, the therapeutic course requires numerous injections, posing a burden on patients. Nonadherence to treatmen...